Abstract: Inclusion complexes are provided containing a targeted carrier non-covalently associated with an active agent. The targeted carrier includes an inclusion host that binds the active agent or a binding partner attached to the active agent. The targeted carrier includes a targeting moiety attached to the inclusion host or to a polymer or linker attached thereto. Pharmaceutical formulations of the inclusion complexes are provided. Methods of making the inclusion complexes and formulations thereof are provided. Methods of using the inclusion complexes and formulations are provided. In some embodiments the inclusion complex includes a progesterone or estrogen targeting moiety that targets the inclusion complex to cancer cells. The targeting can cause internalization of the active agent in the target cells. In some embodiments the active agent is an anthracycline such as doxorubicin and the target cells are cancer cells.

Abstract: A technique includes receiving, by a user device from a base station in a wireless network, a frequency offset information (FOI), adjusting, by the user device, an uplink transmit frequency based on the frequency offset information, and transmitting, by the user device, at least one of data and control information to the base station based on the adjusted uplink transmit frequency.

Abstract: A method of fabricating a semiconductor device is disclosed. The method includes the steps of forming recesses in a semiconductor substrate; epitaxial growing a first SiGe seed layer with constant Ge content in the recesses; epitaxial growing a second SiGe layer with a constant Ge content higher than the Ge content of first SiGe seed layer on the first SiGe seed layer; epitaxial growing a third SiGe layer with a constant Ge content lower than the Ge content of the second SiGe layer; and forming a cap layer on the third SiGe layer.

Abstract: Provided herein are compositions, formulations, kits, and methods for improving or modifying cognitive performance in an individual having normal-age related cognitive decline. The composition can include an amount of a blueberry extract, L-carnosine, a green tea extract, vitamin D3, and a grape extract. The composition can be included in a pharmaceutical formulation and be administered to a subject having normal-age related cognitive decline according to a dosing regimen.

Abstract: A method of fabricating a semiconductor device is disclosed. The method includes the steps of forming recesses in a semiconductor substrate; epitaxial growing a first SiGe seed layer with constant Ge content in the recesses; epitaxial growing a second SiGe layer with a constant Ge content higher than the Ge content of first SiGe seed layer on the first SiGe seed layer; epitaxial growing a third SiGe layer with a constant Ge content lower than the Ge content of the second SiGe layer; and forming a cap layer on the third SiGe layer.

Abstract: The invention relates to a pharmaceutical composition comprising an ionic co-crystal (ICC) of lithium with salicylic acid and 1-proline (LISPRO). The pharmaceutical composition can further comprise an anti-inflammatory agent, for example, salicylic acid. An embodiment of the invention provides a method for treating Fragile X Syndrome (FXS) in a subject by administering to the subject a composition comprising a pharmaceutically effective amount of LISPRO.

Abstract: Features and advantages of the present disclosure include a multimode voltage controlled oscillator (VCO). In one embodiment, a circuit comprises a VCO, first and second transistors, and first and second capacitive attenuators. The first and second transistors are cross coupled through the attenuators. In a first mode, the first and second transistors are turned off, and the capacitive attenuators attenuate a signal on output terminals of the VCO at control inputs of the first and second transistors. In another mode, the first and second transistors are turned on, and the capacitive attenuation is reduced or turned off so that control inputs of the first and second transistors receive signals on the outputs of the VCO.

Abstract: A display device including a substrate, a light absorption layer, an optical matching layer, a first transparent electrode, a light emitting layer, and a second transparent electrode is provided. The light absorption layer is disposed on the substrate, and the optical matching layer is disposed on the light absorption layer. The first transparent electrode is disposed on the optical matching layer, the light emitting layer is disposed on the first transparent electrode, and the second transparent electrode is disposed on the light emitting layer. An output luminance and a reflectance of ambient light are controlled by adjusting refractive indices of the optical matching layer and the light absorption layer.

Abstract: A display device including a substrate, a light absorption layer, an optical matching layer, a first transparent electrode, a light emitting layer, and a second transparent electrode is provided. The light absorption layer is disposed on the substrate, and the optical matching layer is disposed on the light absorption layer. The first transparent electrode is disposed on the optical matching layer, the light emitting layer is disposed on the first transparent electrode, and the second transparent electrode is disposed on the light emitting layer. An output luminance and a reflectance of ambient light are controlled by adjusting refractive indices of the optical matching layer and the light absorption layer.

Abstract: Human umbilical cord blood-derived monocytes that markedly promote A? clearance through heterodimerization of sAPP? with A? and resultant sAPP? production for prevention or treatment of Alzheimer's disease and other neurodegenerative disorders (including stroke and TBI). It was discovered that multiple low-dose infusions of human umbilical cord blood cells (HUCBCs) ameliorate cognitive impairments and reduce A?-associated neuropathology in PSAPP transgenic mice, which markedly promotes amyloid precursor protein (APP) ?-cleavage and resultant sAPP? production for pharmaceutical purposes, in particular for treating or slowing the progression of Alzheimer's disease.

Abstract: A method includes receiving, at a user equipment, a signal including cell-specific reference signals from a number of cells. Cell-specific reference signal(s) are measured from one of the cells to determine measured result(s). The user equipment, based on the measured result(s) meeting first criteria, performs interference cancelation to cancel the cell-specific reference signal(s) corresponding to the one cell from the signal. The user equipment performs the measuring and the performing the interference cancelation for additional ones of the cells until second criteria are met. The user equipment uses measured cell-specific reference signals having their interference canceled to reduce an effect of interference from corresponding cells on communications between the user equipment and a base station. A base station may store cell search information that can be sent to the user equipment to help the user equipment perform the previous method.

Abstract: The invention concerns methods and compositions for treating a neuropsychiatric disorder, wherein the method comprises administering an effective amount of a co-crystal of lithium to a subject in need thereof, wherein the co-crystal comprises lithium, or a pharmaceutically acceptable salt thereof, and an amino acid.

Abstract: A method and apparatus can be configured to receive a first scheduling request. The first scheduling request corresponds to a request for a first access point to process data. The method can also include transmitting a second scheduling request. The second scheduling request corresponds to a request to transmit data to a second access point. The transmitting the second scheduling request comprises transmitting the second scheduling request before the data is processed at the first access point.

Abstract: The present invention is directed to semiconductor processes and devices. More specifically, embodiments of the present invention provide a semiconductor device that comprises a diamond-shaped cavity, and the shaped cavity is filled with silicon and germanium material. There are other embodiments as well.

Abstract: The present invention provides fusion peptides, compositions, methods and kits for treating, reducing the risk of, lessening the severity of, preventing, or delaying the onset of amyloid-related disorders, such as Alzheimer's disease and HIV associated neurocognitive impairment.

Abstract: Systems, methods, apparatuses, and computer program products for random access channel (RACH) design using basis functions are provided. One method includes receiving, at an access point employing a receiver with Q antennas, a random access channel (RACH) preamble sent from a mobile unit. The receiving may comprise receiving the same RACH preamble at B different time intervals where the access point beamforms with a different beam selected from B basis function beams at each of the different time intervals.

Abstract: At a wireless node in a wireless network, multiple interference estimation resources are received in a time-frequency resource space. The multiple interference estimation resources are resource elements in an assigned physical shared channel of the time-frequency resource space that do not contain physical shared channel data for the wireless node. An interference covariance matrix is determined from received signals on the multiple interference estimation resources. Symbol estimates are determined for a desired signal based in part by using the interference covariance matrix. Methods, computer programs and products and apparatus are disclosed. The techniques may be used for uplink, downlink, or D2D communications.

Abstract: The invention concerns methods and compositions for treating a neuropsychiatric disorder, wherein the method comprises administering an effective amount of a co-crystal of lithium to a subject in need thereof, wherein the co-crystal comprises lithium, or a pharmaceutically acceptable salt thereof, and an amino acid.